APA (7th ed.) Citation

Z, K., OP, N., W, X., B, U., CI, F., RM, O., & A, D. (2022). Inflammatory breast cancer with excellent response to pembrolizumab-chemotherapy combination: A case report. Breast disease, 41(1), 255. https://doi.org/10.3233/BD-210041

Chicago Style (17th ed.) Citation

Z, Kharel, Nemer OP, Xi W, Upadhayaya B, Falkson CI, O'Regan RM, and Dhakal A. "Inflammatory Breast Cancer with Excellent Response to Pembrolizumab-chemotherapy Combination: A Case Report." Breast Disease 41, no. 1 (2022): 255. https://doi.org/10.3233/BD-210041.

MLA (9th ed.) Citation

Z, Kharel, et al. "Inflammatory Breast Cancer with Excellent Response to Pembrolizumab-chemotherapy Combination: A Case Report." Breast Disease, vol. 41, no. 1, 2022, p. 255, https://doi.org/10.3233/BD-210041.